Change of angiotensin II-like activity in arterial blood induced by haemorrhage in immature and adult rabbits. 1970

F Broughton Pipkin, and J C Mott, and N R Roberton

UI MeSH Term Description Entries
D001810 Blood Volume Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME. Blood Volumes,Volume, Blood,Volumes, Blood
D002339 Carotid Arteries Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. Arteries, Carotid,Artery, Carotid,Carotid Artery
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

F Broughton Pipkin, and J C Mott, and N R Roberton
January 1968, The Journal of physiology,
F Broughton Pipkin, and J C Mott, and N R Roberton
May 1969, The Journal of physiology,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 1969, The Journal of physiology,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 1979, Biology of the neonate,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 1984, Clinical and experimental pharmacology & physiology,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 1973, Scandinavian journal of clinical and laboratory investigation,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 2016, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
F Broughton Pipkin, and J C Mott, and N R Roberton
January 1974, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!